These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24424132)

  • 21. Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives.
    Leal B; Afonso IF; Rodrigues CR; Abreu PA; Garrett R; Pinheiro LC; Azevedo AR; Borges JC; Vegi PF; Santos CC; da Silveira FC; Cabral LM; Frugulhetti IC; Bernardino AM; Santos DO; Castro HC
    Bioorg Med Chem; 2008 Sep; 16(17):8196-204. PubMed ID: 18701299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents.
    Emmadi NR; Bingi C; Kotapalli SS; Ummanni R; Nanubolu JB; Atmakur K
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2918-22. PubMed ID: 26048808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.
    Devegowda VN; Kim JH; Han KC; Yang EG; Choo H; Pae AN; Nam G; Choi KI
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1630-3. PubMed ID: 20138760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies.
    Santhosh Kumar G; Poornachandra Y; Kumar Gunda S; Ratnakar Reddy K; Mohmed J; Shaik K; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2328-2337. PubMed ID: 29798826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of novel 1,2,3-triazole substituted-N-alkyl/aryl nitrone derivatives, their anti-inflammatory and anticancer activity.
    Sambasiva Rao P; Kurumurthy C; Veeraswamy B; Santhosh Kumar G; Poornachandra Y; Ganesh Kumar C; Vasamsetti SB; Kotamraju S; Narsaiah B
    Eur J Med Chem; 2014 Jun; 80():184-91. PubMed ID: 24780595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
    Hafez HN; El-Gazzar ABA
    Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase inhibitors. Part 6: design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity.
    Kojima A; Takita S; Sumiya T; Ochiai K; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Kohno Y
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5311-6. PubMed ID: 23988356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues.
    Jian XE; Yang F; Jiang CS; You WW; Zhao PL
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127025. PubMed ID: 32063430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents.
    Abd El Hamid MK; Mihovilovic MD; El-Nassan HB
    Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.
    Baviskar AT; Banerjee UC; Gupta M; Singh R; Kumar S; Gupta MK; Kumar S; Raut SK; Khullar M; Singh S; Kumar R
    Bioorg Med Chem; 2013 Sep; 21(18):5782-93. PubMed ID: 23920485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents.
    Kumar D; Narayanam MK; Chang KH; Shah K
    Chem Biol Drug Des; 2011 Mar; 77(3):182-8. PubMed ID: 21251232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors.
    Park A; Hwang J; Lee JY; Heo EJ; Na YJ; Kang S; Jeong KS; Kim KY; Shin SJ; Lee H
    Bioorg Med Chem Lett; 2021 Sep; 47():128226. PubMed ID: 34182093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Aminopyrazolo[3,4-b]pyridine: Effective Precursor for Barium Hydroxide-Mediated Three Components Synthesis of New Mono- and Bis(pyrimidines) with Potential Cytotoxic Activity.
    Sanad SMH; Mekky AEM
    Chem Biodivers; 2022 Jan; 19(1):e202100500. PubMed ID: 34784450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
    Nantka-Namirski P; Kaczmarek L
    Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation.
    Zhai M; Liu S; Gao M; Wang L; Sun J; Du J; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
    Eur J Med Chem; 2019 Apr; 168():426-435. PubMed ID: 30831410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of 5-(4-hydroxy-3-methylphenyl) -5- (substituted phenyl)-4, 5-dihydro-1H-1-pyrazolyl-4-pyridylmethanone derivatives with anti-viral activity.
    Ali MA; Shaharyar M; De Clercq E
    J Enzyme Inhib Med Chem; 2007 Dec; 22(6):702-8. PubMed ID: 18237022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity.
    Farahat AA; Samir EM; Zaki MY; Serya RAT; Abdel-Aziz HA
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100302. PubMed ID: 34796536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-activity relationship, and docking study.
    Basnet A; Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jahng Y; Na Y; Cho WJ; Kwon Y; Lee CS; Lee ES
    Bioorg Med Chem Lett; 2010 Jan; 20(1):42-7. PubMed ID: 19954977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.